Literature DB >> 2495523

Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer.

M A Lucero1, D Sanchez, A R Ochoa, F Brunel, G N Cohen, F E Baralle, M M Zakin.   

Abstract

The identification of the binding sites for liver nuclear proteins present in the enhancer that control the cell specific transcription of the human apolipoprotein AII gene is reported. Five adjacent binding sites (motifs I to V) were identified. The motifs III, IV and V can be occupied differently by liver or HeLa nuclear proteins. Two hypersensitive zones (between motifs II-III and IV-V) are present only when liver nuclear extracts were tested. A first characterization of the factors reveal that motif IV interacts with the hepatic transcription factors Tf-LF1 (29) and LF-A1 (28, 30). A CCAAT binding protein, different from CTF/NF1, appears to bind to the motif II. The different binding sites share specific DNA sequences principally with 5' regulatory regions of other apolipoprotein genes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495523      PMCID: PMC317596          DOI: 10.1093/nar/17.6.2283

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity.

Authors:  J F Oram; J J Albers; M C Cheung; E L Bierman
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

2.  Effect of apolipoprotein A-II on the structure of high-density lipoproteins: relationship to the activity of lecithin:cholesterol acyl transferase in vitro.

Authors:  A M Scanu; P Lagocki; J Chung
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

3.  In vitro activation of the enzymic activity of hepatic lipase by apoA-II.

Authors:  C E Jahn; J C Osborne; E J Schaefer; H B Brewer
Journal:  FEBS Lett       Date:  1981-08-31       Impact factor: 4.124

4.  On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II.

Authors:  C Edelstein; M Halari; A M Scanu
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.

Authors:  G Fager; O Wiklund; S O Olofsson; L Wilhelmsen; G Bondjers
Journal:  Arteriosclerosis       Date:  1981 Jul-Aug

Review 7.  The plasma lecithins:cholesterol acyltransferase reaction.

Authors:  J A Glomset
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

8.  Cell type-specific expression of the human apoB gene is controlled by two cis-acting regulatory regions.

Authors:  H K Das; T Leff; J L Breslow
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

9.  Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.

Authors:  M C Cheung; J J Albers
Journal:  J Lipid Res       Date:  1982-07       Impact factor: 5.922

10.  Transport of apolipoproteins A-I and A-II by human thoracic duct lymph.

Authors:  D W Anderson; E J Schaefer; T J Bronzert; F T Lindgren; T Forte; T E Starzl; G D Niblack; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more
  9 in total

1.  The transcription factor LF-A1 interacts with a bipartite recognition sequence in the promoter regions of several liver-specific genes.

Authors:  D P Ramji; M H Tadros; E M Hardon; R Cortese
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

2.  Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor.

Authors:  D Kardassis; M Hadzopoulou-Cladaras; D P Ramji; R Cortese; V I Zannis; C Cladaras
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

3.  Liver-specific gene expression: A-activator-binding site, a promoter module present in vitellogenin and acute-phase genes.

Authors:  M Kaling; W Kugler; K Ross; C Zoidl; G U Ryffel
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

4.  Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.

Authors:  N Vu-Dac; K Schoonjans; V Kosykh; J Dallongeville; R A Heyman; B Staels; J Auwerx
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Two regulatory elements of similar structure and placed in tandem account for the repressive activity of the first intron of the human apolipoprotein A-II gene.

Authors:  J P Bossu; F L Chartier; J C Fruchart; J Auwerx; B Staels; B Laine
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region.

Authors:  J M Lacorte; E Fourniat; D Pastier; J Chambaz; A Ribeiro; P Cardot
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

7.  Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Authors:  N Vu-Dac; K Schoonjans; V Kosykh; J Dallongeville; J C Fruchart; B Staels; J Auwerx
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Expression of laminin gamma 1 cultured hepatocytes involves repeated CTC and GC elements in the LAMC1 promoter.

Authors:  F Levavasseur; J Liétard; K Ogawa; N Théret; P D Burbelo; Y Yamada; A Guillouzo; B Clément
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

Review 9.  Apolipoprotein A-II, a Player in Multiple Processes and Diseases.

Authors:  Gabriela Florea; Irina Florina Tudorache; Elena Valeria Fuior; Radu Ionita; Madalina Dumitrescu; Ioana Madalina Fenyo; Violeta Georgeta Bivol; Anca Violeta Gafencu
Journal:  Biomedicines       Date:  2022-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.